CB45562-21 - 0x0000000000006522

Males & Females of Non-Childbearing Potential

Mountain

* Stipend may pay up to reflected amount.
Start Date: 
February 16, 2025 - 3:15pm
End Date: 
March 10, 2025 - 1:45pm

Study Details

Study Number: CB45562
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease
Route of Administration: Oral
Blood Draws: 35

Study Schedule

Schedule Type: Long Term
Study Length: 10 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Tuesday 2/11/2025
Thursday 2/13/2025
Friday 2/14/2025
Saturday 2/15/2025

Doctor Exam Dates:

Event Day Event Date
Tuesday 2/11/2025
Thursday 2/13/2025
Friday 2/14/2025
Saturday 2/15/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 2/16/2025 3:15:00 PM Wednesday 2/26/2025 9:45:00 AM 1 Lincoln
Phone participant Monday 3/10/2025 1:45:00 PM 1 Lincoln